Home > Financial Ratios > WINDLAS BIOTECH

WINDLAS BIOTECH
Price to Cash Earnings (PCE)

    Back to All Ratios
AD     Remove this Ad

WINDLAS BIOTECH Last 5 Year Price to Cash Earnings (PCE) History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   PCE(x) 24.5314.888.579.11-

What is the latest Price to Cash Earnings (PCE) ratio of WINDLAS BIOTECH ?

The latest Price to Cash Earnings (PCE) ratio of WINDLAS BIOTECH is 24.53 based on Mar2025 Consolidated results.
Year Price to Cash Earnings (PCE)
Mar202524.53
Mar202414.88
Mar20238.57
Mar20229.11
Mar2021-

How is Price to Cash Earnings (PCE) of WINDLAS BIOTECH Trending?

Years Price to Cash Earnings (PCE) % Change
Mar2025 24.53
64.85
Mar2024 14.88
73.63
Mar2023 8.57
-5.93
Mar2022 9.11
0
Mar2021 0 -

Other Financial Ratios of WINDLAS BIOTECH


Compare Price to Cash Earnings (PCE) ratio of peers of WINDLAS BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
WINDLAS BIOTECH ₹1,615.1 Cr 5.3% 0.4% -15.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹430,837.0 Cr 1% 3.8% 0.6% Stock Analytics
DIVIS LABORATORIES ₹159,175.0 Cr -1.7% -4.1% 3.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹144,394.0 Cr -0% -3% 33.3% Stock Analytics
DR REDDYS LABORATORIES ₹106,999.0 Cr -1.3% -1.3% 8.6% Stock Analytics
CIPLA ₹100,379.0 Cr -1.1% -6.3% -18.3% Stock Analytics


WINDLAS BIOTECH Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
WINDLAS BIOTECH

5.3%

0.4%

-15.5%

SENSEX

-0.8%

-11.7%

-3.6%


You may also like the below Video Courses